Clinical trial
Treatment of Age-Related Macular Degeneration With Anecortave Acetate
NCT00211458 · Manhattan Eye, Ear & Throat Hospital, Other · Completed
Key facts
| NCT number | NCT00211458 |
|---|---|
| Title | Treatment of Age-Related Macular Degeneration With Anecortave Acetate |
| Official title | Treatment of Age-Related Macular Degeneration With Open-label Anecortave Acetate Sterile Suspension (15mg) Following Failed Treatment With Photodynamic Therapy With Visudyne |
| Lead sponsor | Manhattan Eye, Ear & Throat Hospital, Other |
| Collaborators | Alcon Research Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Drug |
| Interventions | Anecortave Acetate Sterile Suspension (15 mg) |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 25, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: